Content about Diabetes

September 17, 2012

An organization focused on Type 1 diabetes research announced Monday the winners of a competition to find new ways to treat the disease.

NEW YORK — An organization focused on Type 1 diabetes research announced Monday the winners of a competition to find new ways to treat the disease.

September 14, 2012

Drug makers Boehringer Ingelheim and Eli Lilly have created a new online educational program for people with Type 2 diabetes.

INDIANAPOLIS — Drug makers Boehringer Ingelheim and Eli Lilly have created a new online educational program for people with Type 2 diabetes.

The companies, which have had a deal to develop drugs for diabetes since January 2011 and co-market the drugs Tradjenta (linagliptin) and Jentadueto (linagliptin and metformin), announced Thursday the creation of My Well Planner, a lifestyle-improvement program for adults with the disease.

September 11, 2012

Louisiana pharmacist Randy Mire testified before Congress Tuesday that efforts to combat the diabetes epidemic in his home state and elsewhere would be significantly undermined if independent community pharmacies like his are forced to stop offering diabetes testing supplies as a result of Medicare’s competitive bidding program for durable medical equipment, according to a National Community Pharmacists Association release.

ALEXANDRIA, Va. — Louisiana pharmacist Randy Mire testified before Congress Tuesday that efforts to combat the diabetes epidemic in his home state and elsewhere would be significantly undermined if independent community pharmacies like his are forced to stop offering diabetes testing supplies as a result of Medicare’s competitive bidding program for durable medical equipment, according to a National Community Pharmacists Association release.

Mire appeared on behalf of NCPA before the U.S. House Small Business Subcommittee on Healthcare and Technology.

September 4, 2012

Lilly Diabetes announced that it has launched a new mobile application designed for caregivers and healthcare providers who support people with Type 1 diabetes.

INDIANPOLIS — Lilly Diabetes announced that it has launched a new mobile application designed for caregivers and healthcare providers who support people with Type 1 diabetes.

The Lilly Glucagon mobile app is an interactive tool designed to teach caregivers how to use severe hypoglycemia treatment Glucagon (1-mg) for injection through simulated practice, thus helping caregivers better understand Glucagon's role in diabetes management. The Lilly Glucagon mobile app includes:

  • Information about severe hypoglycemia and Glucagon;

August 30, 2012

NextGen Healthcare Information Systems on Wednesday announced a telemedicine agreement with Nipro Diagnostics that would enable users of the company's NextGen Ambulatory EHR instant access to data points captured by patients at home who are using the Nipro TrueResult blood-glucose monitoring system.

HORSHAM, Pa. — NextGen Healthcare Information Systems on Wednesday announced a telemedicine agreement with Nipro Diagnostics that would enable users of the company's NextGen Ambulatory EHR instant access to data points captured by patients at home who are using the Nipro TrueResult blood-glucose monitoring system. 

August 30, 2012

According to the Centers for Disease Control and Prevention, about 1.9 million new cases of diabetes are diagnosed each year. To help its customers better understand this illness, Sam's Club pharmacy locations are offering free diabetes and vision screenings (diabetes is a leading cause of blindness) for members and the public on Saturday, Sept. 8 from 11 a.m. to 3 p.m.

BENTONVILLE, Ark. — According to the Centers for Disease Control and Prevention, about 1.9 million new cases of diabetes are diagnosed each year. To help its customers better understand this illness, Sam's Club pharmacy locations are offering free diabetes and vision screenings (diabetes is a leading cause of blindness) for members and the public on Saturday, Sept. 8 from 11 a.m. to 3 p.m.

Sam's Club's free diabetes screenings are valued at more than $150 and include:

  • Glucose tests;

August 21, 2012

The University of Chicago Medicine and Walgreens are teaming up to launch a "Food Rx" initiative that will help people with diabetes improve their eating habits by overcoming two major hurdles when shopping for food: access and affordability, the groups announced Aug. 15.

CHICAGO — The University of Chicago Medicine and Walgreens are teaming up to launch a "Food Rx" initiative that will help people with diabetes improve their eating habits by overcoming two major hurdles when shopping for food: access and affordability, the groups announced Aug. 15.

August 17, 2012

Even just a few years ago, this kind of collaboration between a healthcare group and a drug store around a comprehensive food nutrition education program probably wouldn't have happened. Truth be told, it really isn't happening today. And that's because Walgreens isn't a drug store. Walgreens is a health and daily living solutions store.

WHAT IT MEANS AND WHY IT'S IMPORTANT — Even just a few years ago, this kind of collaboration between a healthcare group and a drug store around a comprehensive food nutrition education program probably wouldn't have happened. Truth be told, it really isn't happening today. And that's because Walgreens isn't a drug store. Walgreens is a health and daily living solutions store.

August 16, 2012

A nonprofit healthcare education organization and a for-profit company that uses healthcare education technology to promote best practices in medicine are developing educational programs to improve chronic disease care.

MINNEAPOLIS — A nonprofit healthcare education organization and a for-profit company that uses healthcare education technology to promote best practices in medicine are developing educational programs to improve chronic disease care.

August 15, 2012

The University of Chicago Medicine and Walgreens are teaming up to launch a "Food Rx" initiative that will help people with diabetes improve their eating habits by overcoming two major hurdles when shopping for food: access and affordability, the groups announced Wednesday.

CHICAGO — The University of Chicago Medicine and Walgreens are teaming up to launch a "Food Rx" initiative that will help people with diabetes improve their eating habits by overcoming two major hurdles when shopping for food: access and affordability, the groups announced Wednesday.

August 15, 2012

Watson Pharmaceuticals is suing the Food and Drug Administration, alleging that an agency decision would improperly delay its release of a generic drug for diabetes, the company said Wednesday.

PARSIPPANY, N.J. — Watson Pharmaceuticals is suing the Food and Drug Administration, alleging that an agency decision would improperly delay its release of a generic drug for diabetes, the company said Wednesday.

August 13, 2012

Regulators have approved a biotech drug made by Genentech for treating a complication related to diabetes.

SILVER SPRING, Md. — Regulators have approved a biotech drug made by Genentech for treating a complication related to diabetes.

The Food and Drug Administration approved Lucentis (ranibizumab) for diabetic macular edema, a cause of vision loss in people with diabetes. The drug already was approved for age-related macular degeneration.

August 8, 2012

Bristol-Myers Squibb has bought a majority stake in drug maker Amylin Pharmaceuticals, Bristol said Wednesday.

NEW YORK — Bristol-Myers Squibb has bought a majority stake in drug maker Amylin Pharmaceuticals, Bristol said Wednesday.

The New York-based drug maker said that 140.5 million shares of Amylin had been put up for sale at $31 per share, and that it now owned 85.55% of the San Diego-based company. Bristol said it planned to acquire the rest of Amylin's shares Wednesday as well.

August 3, 2012

Philosys is seeking regulatory approval from the Food and Drug Administration for its blood-glucose monitoring system.

NEW YORK — Philosys is seeking regulatory approval from the Food and Drug Administration for its blood-glucose monitoring system.

Gmate Smart, which the company calls "the smallest and most innovative meter in the world," is a blood-glucose meter that works with the headphone connector of the iPhone, iPad and iPod.

July 31, 2012

A drug made by Bristol-Myers Squibb and AstraZeneca improved several measures of blood-sugar control in Type 2 diabetes patients at high risk of cardiovascular disease, according to results of a late-stage clinical trial announced Monday.

PRINCETON, N.J. — A drug made by Bristol-Myers Squibb and AstraZeneca improved several measures of blood-sugar control in Type 2 diabetes patients at high risk of cardiovascular disease, according to results of a late-stage clinical trial announced Monday.

July 30, 2012

Why is the news that CVS Caremark Charitable Trust has teamed up with the National Association of Community Health Centers important? $300 billion a year and an alarming rise in the number of Americans suffering from chronic diseases. That’s why.

WHAT IT MEANS AND WHY IT'S IMPORTANT — Why is the news that CVS Caremark Charitable Trust has teamed up with the National Association of Community Health Centers important? $300 billion a year and an alarming rise in the number of Americans suffering from chronic diseases. That’s why.

(THE NEWS: CVS Caremark Charitable Trust, NACHC form 'Innovations in Community Health' program. For the full story, click here)

July 30, 2012

Drug maker Takeda Pharmaceutical has resubmitted regulatory approval applications for two drugs designed to treat diabetes, the company said.

DEERFIELD, Ill. — Drug maker Takeda Pharmaceutical has resubmitted regulatory approval applications for two drugs designed to treat diabetes, the company said.

Takeda announced the resubmission to the Food and Drug Administration of applications for alogliptin and a drug that combines alogliptin with pioglitazone, the active ingredient in the Takeda drug Actos.

July 27, 2012

A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

SILVER SPRING, Md. — A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

July 24, 2012

Walmart has launched an effort to help diabetes patients save on their disease management products.

BENTONVILLE, Ark. — Walmart has launched an effort to help diabetes patients save on their disease management products.

July 23, 2012

The Centers for Medicare and Medicaid Services on Monday hosted a public meeting to entertain a controversial payment adjustment — called "inherent reasonableness" — in reimbursing for non-mail-order diabetes supplies.

ALEXANDRIA, Va. — The Centers for Medicare and Medicaid Services on Monday hosted a public meeting to entertain a controversial payment adjustment — called "inherent reasonableness" — in reimbursing for non-mail-order diabetes supplies.

July 23, 2012

Extended use of the oral DPP-4 inhibitor linagliptin to lower blood-glucose levels by Type 2 diabetes patients is effective, according to a new study.

NEW YORK — Extended use of the oral DPP-4 inhibitor linagliptin to lower blood-glucose levels by Type 2 diabetes patients is effective, according to a new study.

A team of eight researchers — four of which work for drug maker Boehringer Ingelheim — examined 2,121 Type 2 diabetes patients that had taken part in four previous 24-week randomized, double-blind, placebo-controlled trials in order to monitor them for a further 78 weeks. The participants who took part in the extended trial came from 231 sites in 32 countries.

July 19, 2012

Roche on Wednesday announced that it has received clearance from the Food and Drug Administration for its Accu-Chek Combo system for insulin pump therapy.

INDIANAPOLIS — Roche on Wednesday announced that it has received clearance from the Food and Drug Administration for its Accu-Chek Combo system for insulin pump therapy.

July 18, 2012

Jacques Duplessis on Monday pleaded guilty to engaging in a scheme to sell approximately 6,000 boxes of counterfeit LifeScan One Touch diabetic test strips that he purchased from suppliers in China and England, announced U.S. attorney Zane David Memeger.

PHILADELPHIA — Jacques Duplessis on Monday pleaded guilty to engaging in a scheme to sell approximately 6,000 boxes of counterfeit LifeScan One Touch diabetic test strips that he purchased from suppliers in China and England, announced U.S. attorney Zane David Memeger.

July 16, 2012

Employees with such chronic diseases as asthma, diabetes and high blood pressure spend fewer days out of the office when they are adherent to their medications, according to new research conducted by CVS Caremark and Truven Health Analytics (previously the healthcare business of Thomson Reuters).

WOONSOCKET, R.I. — Employees with such chronic diseases as asthma, diabetes and high blood pressure spend fewer days out of the office when they are adherent to their medications, according to new research conducted by CVS Caremark and Truven Health Analytics (previously the healthcare business of Thomson Reuters).

July 16, 2012

British drug maker GlaxoSmithKline will acquire development partner Human Genome Sciences for $3.6 billion, GSK said Monday.

LONDON — British drug maker GlaxoSmithKline will acquire development partner Human Genome Sciences for $3.6 billion, GSK said Monday.

The deal, worth $14.25 per share, would give GSK full ownership of the lupus drug Benlysta (belimumab), as well as albiglutide, an experimental drug for diabetes, and darapladib, an experimental heart disease drug.